Showing results (171-180 of 206) with videos related to

Sort By:
Pageof 21
Mayo Clinic Proceedings|March 1, 1989
Intraoperative blood loss and patient and graft survival in orthotopic liver transplantation: their relationship to clinical and laboratory dataT L Motschman, H F Taswell, M E Brecher, et al.
BMJ (Clinical Research Ed.)|October 30, 1993
Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infectionL T Mimms, J W Mosley, F B Hollinger, et al.
Transfusion|September 1, 1996
Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C outcomesJ W Mosley, W Huang, D O Stram, et al.
The New England Journal of Medicine|November 20, 1975
Clinical trials of hepatitis B immune globulin. Development of policies and materials for the 1972-1975 studies sponsored by the National Heart and Lung InstituteD M Surgenor, T C Chalmers, M E Conrad, et al.
The Journal of Infectious Diseases|July 1, 1996
Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study GroupM P Busch, E A Operskalski, J W Mosley, et al.
Transplantation|August 15, 1997
Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcomeT Gayowski, N Singh, I R Marino, et al.
Journal of Viral Hepatitis|January 11, 2008
Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirinK R Reddy, S Govindarajan, P Marcellin, et al.
Blood|August 15, 1993
Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. The Transfusion Safety Study GroupJ Hassett, G F Gjerset, J W Mosley, et al.
Blood|September 1, 1994
Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study GroupG F Gjerset, M C Pike, J W Mosley, et al.
Journal of Viral Hepatitis|January 11, 2008
The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapyJ W Mosley, E A Operskalski, L H Tobler, et al.
Pageof 21